Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Shifting a paradigm: highlights of model informed drug development in dosage selection and optimization for oncology products.

The oncologist·2026
Same author

Shifting a paradigm: highlights of model informed drug development in dosage selection and optimization for oncology products.

The oncologist·2026
Same author

In-depth Evaluation of the Olink Target 48 Cytokine Panel: Inter-Laboratory Evaluation of Performance and Reliability for Biomarker Studies in Oncology.

The AAPS journal·2026
Same author

Anti-drug Antibody Validation Testing and Reporting Harmonization Addendum.

The AAPS journal·2026
Same author

2025 White Paper on Recent Issues in Bioanalysis: Redosing Patients with AAV Gene Therapy; CRS Immunogenicity Risk; Shedding Assays; NHP Studies Immunogenicity; CMC vs Bioanalytical Assays; Artificial Intelligence-Powered Genomic Pipelines for NGS (<u>PART 3A</u> - Recommendations on Gene, Cell, and Vaccine Therapies Immunogenicity & Technologies; Biotherapeutics & Biosimilars Immunogenicity Assessment & Clinical Relevance <u>PART 3B</u> - Regulatory Agencies' Input on Immunogenicity/Technologies of Biotherapeutics, Gene, Cell & Vaccine Therapies).

Bioanalysis·2026
Same author

US Food and Drug Administration Approval Summary: Imetelstat for Selected Patients With Low- to Intermediate-1 Risk Myelodysplastic Syndromes With Transfusion-Dependent Anemia.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025
Same journal

Whole-Body Pharmacokinetics of Ionizable Lipid, mRNA, and the Expressed Antibody following Intravenous Administration of mRNA-Loaded Lipid Nanoparticles.

The AAPS journal·2026
Same journal

Simple Hydrodynamic Molecular Weight Model for Rapid Assessment of Therapeutic Protein Oligomerization States in Formulation.

The AAPS journal·2026
Same journal

Guiding the Molnupiravir Tablet Formulation Using Physiologically Based Biopharmaceutics Modeling and Successfully Establishing Dissolution Safe Space.

The AAPS journal·2026
Same journal

Correction: Nanotechnology-enhanced Natural Products for Cancer Chemoprevention: Molecular Mechanisms and Clinical Translation.

The AAPS journal·2026
Same journal

Quantitative Estimation of Clinical Intrasubject Variability of a Pharmacokinetic Parameter.

The AAPS journal·2026
Same journal

Targeting Pyruvate Kinase M2: Signal Transduction Pathways and Exploration of Cancer Therapeutic Strategies.

The AAPS journal·2026
See all related articles

Related Experiment Video

Updated: Jan 2, 2026

Multi-analyte Biochip MAB Based on All-solid-state Ion-selective Electrodes ASSISE for Physiological Research
08:03

Multi-analyte Biochip MAB Based on All-solid-state Ion-selective Electrodes ASSISE for Physiological Research

Published on: April 18, 2013

17.7K

AAPS Workshop Report on ICH M10.

Brian Booth1, Faye Vazvaei2, Eric Fluhler3

  • 1Office of Translational Sciences, Office of Clinical Pharmacology, CDER, US FDA, Silver Spring, Maryland, USA.

The AAPS Journal
|December 12, 2019
PubMed
Summary
This summary is machine-generated.

The International Council for Harmonization (ICH) released a draft guideline (M10) for bioanalytical method validation (BMV) to harmonize global pharmaceutical submissions. A workshop identified areas for discussion and potential revisions to the draft BMV guideline.

More Related Videos

Integrative Toolkit to Analyze Cellular Signals: Forces, Motion, Morphology, and Fluorescence
14:55

Integrative Toolkit to Analyze Cellular Signals: Forces, Motion, Morphology, and Fluorescence

Published on: March 5, 2022

4.3K
Probing The Structure And Dynamics Of Nucleosomes Using Atomic Force Microscopy Imaging
09:52

Probing The Structure And Dynamics Of Nucleosomes Using Atomic Force Microscopy Imaging

Published on: January 31, 2019

12.0K

Related Experiment Videos

Last Updated: Jan 2, 2026

Multi-analyte Biochip MAB Based on All-solid-state Ion-selective Electrodes ASSISE for Physiological Research
08:03

Multi-analyte Biochip MAB Based on All-solid-state Ion-selective Electrodes ASSISE for Physiological Research

Published on: April 18, 2013

17.7K
Integrative Toolkit to Analyze Cellular Signals: Forces, Motion, Morphology, and Fluorescence
14:55

Integrative Toolkit to Analyze Cellular Signals: Forces, Motion, Morphology, and Fluorescence

Published on: March 5, 2022

4.3K
Probing The Structure And Dynamics Of Nucleosomes Using Atomic Force Microscopy Imaging
09:52

Probing The Structure And Dynamics Of Nucleosomes Using Atomic Force Microscopy Imaging

Published on: January 31, 2019

12.0K

Area of Science:

  • Pharmaceutical Science
  • Regulatory Science
  • Analytical Chemistry

Background:

  • Global pharmaceutical development faces challenges due to differing bioanalytical method validation (BMV) regulatory guidelines worldwide.
  • The International Council for Harmonization (ICH) aims to standardize pharmaceutical development and registration processes.
  • ICH released a draft guideline (M10) for BMV to address harmonization needs.

Framework:

  • The draft ICH M10 guideline provides a comprehensive framework for bioanalytical method validation.
  • The guideline addresses key aspects of BMV for global pharmaceutical submissions.
  • Harmonization of BMV is crucial for efficient and consistent drug development.

Implementation:

  • The American Association of Pharmaceutical Scientists (AAPS) convened a workshop to discuss the draft ICH M10 guideline.
  • Regulatory, industry, and academic scientists participated in the forum.
  • The workshop facilitated a discussion of various perspectives on the draft guideline's content.

Implications:

  • While the draft ICH M10 guideline is generally well-received, specific topics require further discussion and potential revision.
  • The workshop generated recommendations for the expert working group (EWG) responsible for the guideline.
  • Addressing these points will contribute to a more refined and globally accepted BMV standard.